Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for ENvue Medical (FEED) over the last 10 years, with Q3 2025 value amounting to $4.9 million.

  • ENvue Medical's Cash from Financing Activities rose 1832222.22% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 20611.27%. This contributed to the annual value of $1000.0 for FY2024, which is 9997.63% down from last year.
  • Latest data reveals that ENvue Medical reported Cash from Financing Activities of $4.9 million as of Q3 2025, which was up 1832222.22% from $6.8 million recorded in Q2 2025.
  • In the past 5 years, ENvue Medical's Cash from Financing Activities ranged from a high of $6.8 million in Q2 2025 and a low of -$388000.0 during Q2 2021
  • Moreover, its 4-year median value for Cash from Financing Activities was $1.4 million (2021), whereas its average is $2.4 million.
  • Per our database at Business Quant, ENvue Medical's Cash from Financing Activities plummeted by 10064.06% in 2024 and then surged by 1832222.22% in 2025.
  • ENvue Medical's Cash from Financing Activities (Quarter) stood at $3.6 million in 2021, then increased by 18.33% to $4.2 million in 2023, then crashed by 100.64% to -$27000.0 in 2024, then soared by 18322.22% to $4.9 million in 2025.
  • Its Cash from Financing Activities stands at $4.9 million for Q3 2025, versus $6.8 million for Q2 2025 and $1.0 million for Q1 2025.